Olema Pharmaceuticals, Inc.
OLMA
$5.59
-$0.17-2.95%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -43.78M | -30.39M | -33.57M | -34.56M | -30.38M |
| Total Depreciation and Amortization | 132.00K | 128.00K | 116.00K | 95.00K | 94.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.27M | 2.56M | 4.99M | 3.91M | 3.82M |
| Change in Net Operating Assets | 10.50M | -16.28M | 2.18M | 3.53M | -1.09M |
| Cash from Operations | -29.88M | -43.98M | -26.28M | -27.02M | -27.56M |
| Capital Expenditure | -- | -- | 0.00 | 0.00 | -6.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 34.23M | -45.08M | -114.42M | 45.92M | -4.87M |
| Cash from Investing | 34.23M | -45.08M | -114.42M | 45.92M | -4.88M |
| Total Debt Issued | 3.00M | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 982.00K | 236.00K | 250.80M | 92.00K | 15.61M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -6.50M | -14.00K | -6.50M | 0.00 | 0.00 |
| Cash from Financing | -2.52M | 222.00K | 244.30M | 92.00K | 15.61M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.83M | -88.84M | 103.59M | 19.00M | -16.83M |